ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 1 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $22,718,000 | +60.2% | 1,204,600 | 0.0% | 2.53% | +81.4% |
| Q2 2019 | $14,178,000 | -18.3% | 1,204,600 | -5.3% | 1.40% | -11.0% |
| Q1 2019 | $17,355,000 | +190.9% | 1,271,500 | +118.5% | 1.57% | +67.2% |
| Q4 2018 | $5,965,000 | -38.4% | 582,030 | 0.0% | 0.94% | +3.1% |
| Q3 2018 | $9,690,000 | +5.4% | 582,030 | 0.0% | 0.91% | +9.9% |
| Q2 2018 | $9,196,000 | – | 582,030 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |